Assessment of the effectiveness and safety of virtual reality-based telerehabilitation in improving motor function, balance and gait in patients with Parkinson's disease: a protocol for systematic review and meta-analysis

评估基于虚拟现实的远程康复在改善帕金森病患者运动功能、平衡和步态方面的有效性和安全性:系统评价和荟萃分析方案

阅读:1

Abstract

INTRODUCTION: Virtual reality-based telerehabilitation (VR-TR) combines gamified exercises with remote supervision for people with Parkinson's disease (PD). Its effectiveness and safety in PD remain uncertain. This protocol outlines methods to evaluate the effects of VR-TR on functional and clinical outcomes. METHODS AND ANALYSIS: Randomised controlled trials and quasi-experimental studies will be identified in PubMed (National Library of Medicine), Scopus (Elsevier), Cochrane CENTRAL (Cochrane Library) and PEDro (Physiotherapy Evidence Database) from inception to June 2026, with additional searches of grey literature and trial registries. Eligible participants are adults with idiopathic PD. Interventions include immersive or non-immersive VR-TR with remote supervision, compared with conventional physiotherapy, usual care or other active non-VR interventions. Primary outcomes are balance, gait and global motor function; secondary outcomes are quality of life and adverse events. Two reviewers will independently screen, extract data and assess risk of bias. Where possible, meta-analyses will be conducted using RevMan V.5.4, and the certainty of evidence will be appraised with Grading of Recommendations Assessment, Development and Evaluation. ETHICS AND DISSEMINATION: This study does not involve human participants and uses data from published studies; therefore, ethics approval is not required. However, as per institutional requirements, ethical clearance was obtained from the Institutional Ethics Committee of Datta Meghe Institute of Higher Education and Research (DMIHER) (Ref. No.: DMIHER(DU)/IEC/2025/204). Findings will be published in peer-reviewed journals and presented at conferences. PROSPERO REGISTRATION NUMBER: CRD420251009423.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。